News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Acrobot and Finsbury Orthopaedics Sign Co-Marketing Agreement



9/15/2009 1:52:17 PM

London, UK: 15 September 2009 … Acrobot, the medical devices company specialising in computer assisted orthopaedic surgery, today announces a co-marketing arrangement with Finsbury, the orthopaedic implants company, which will see Finsbury and Acrobot closely working together to provide hospitals with a 'one-stop' package for precision navigated hip resurfacing.

The arrangement will see Acrobot placing Navigator, its precision surgical navigation system, alongside Finsbury's state of the art ADEPT® hip resurfacing implant. Acrobot and Finsbury will provide a novel co-marketing proposition, which can provide access to Acrobot’s precision surgical systems to selected hospitals throughout the UK.

Acrobot Navigator enables orthopaedic surgeons to place the components used in hip resurfacing surgery more accurately. By ensuring the implant is positioned correctly, surgical outcomes can be improved because the implant lasts longer due to wear of the components, a major factor in the failure of orthopaedic surgery, being greatly reduced.

The first navigated ADEPT® surgery will take place in the next few weeks with an official launch planned for the British Orthopaedic Association's meeting in mid September.

Graeme Brookes, CEO of Acrobot, said: “We are delighted to have secured this arrangement with Finsbury. This will allow us to manage our presence in the marketplace more effectively, ensuring we are able to provide Acrobot’s cutting edge technology to more surgeons. Finsbury have developed an excellent reputation for their high quality implants, and coupled with our surgical systems, we believe we can provide a highly desirable and competitive package.”

Mike Tuke CEO of Finsbury, added: “Acrobot have an excellent reputation for developing surgical systems which help surgeons to accurately position implant components, and coupled with our own implants and instruments, we believe this co-marketing agreement will ensure surgeons are able to provide their patients with the best possible care."

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES